Girihlet
Immune repertoires
Girihlet operates in diagnostics based in United States, founded in 2012.
Profile
Girihlet is a multi-dimensional platform that will accelerate the discovery of disease-monitoring and therapeutic strategies for complex immune diseases. We develop personalized therapeutics for autoimmune disorders by accurately and sensitively profiling immune repertoire profiles, based on proprietary assays and computational algorithms.
Within the diagnostics space, the company focuses on its core offering rather than a broad product line.
The business is associated with United States.
The company is listed at the SOSV portfolio company stage of development.
Its team size is recorded as 2-10 employees.
It has disclosed roughly $2.5M in funding.
| Sector | Diagnostics |
|---|---|
| Country | United States |
| Founded | 2012 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $2,500,000 |
Website: girihlet.com
Create a free account